| Views | |
|---|---|
| Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 76 |
| November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|
| Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 4 | 3 | 0 | 4 | 11 | 0 | 12 |
| Views | |
|---|---|
| 2023_Kreye_etal.pdf | 25 |
